Tumor Ablation Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Technology (Cryoablation, Radiofrequency (RF) Ablation, Microwave Ablation and Others), Application (Lung Cancer, Liver Cancer, Kidney Cancer, Bone Metastasis and Others), Mode of Treatment (Percutaneous Ablation, Surgical Ablation, Laparoscopic Ablation, Others), and Geography
Report Code: TIPHE100001314 No. of Pages: 150 Category: Medical Device Status: Upcoming
Tumor Ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to "burn" or "freeze" cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor.
The tumor ablation market is anticipated to grow with a significant rate in the coming years, owing to factors such as, Increasing prevalence of cancer in the global population. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for tumor ablation market.
The "Global Tumor Ablation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global tumor ablation market with detailed market segmentation by technology, application, mode of treatment, and geography. The global tumor ablation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the tumor ablation market.
The global tumor ablation market is segmented on the basis of technology, application, mode of treatment, and geography. Based on technology, the market is segmented as, cryoablation, radiofrequency (RF) ablation, microwave ablation and others. The application segment includes, lung cancer, liver cancer, kidney cancer, bone metastasis and others. Based on mode of treatment, the market is segmented as, percutaneous ablation, surgical ablation, laparoscopic ablation and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global tumor ablation market based on technology, application, mode of treatment, and geography. It also provides market size and forecast till 2027 for overall tumor ablation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the tumor ablation market in the coming years, owing to factors such as, enhanced healthcare infrastructure and rising occurrence of cancer in United States and Canada. In addition, increasing health tourism due to inferior treatment charges in Asia Pacific region it is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key tumor ablation market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Healthtronics, Inc., Boston Scientific Corporation, Misonix, Inc., Mermaid Medical A/S, Neuwave Medical, Inc., Medtronic, PLC, Angiodynamics, Inc., Galil Medical, Inc., Edap Tms S.A., Sonacare Medical LLC
The tumor ablation market is anticipated to grow with a significant rate in the coming years, owing to factors such as, Increasing prevalence of cancer in the global population. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for tumor ablation market.
The "Global Tumor Ablation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global tumor ablation market with detailed market segmentation by technology, application, mode of treatment, and geography. The global tumor ablation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the tumor ablation market.
The global tumor ablation market is segmented on the basis of technology, application, mode of treatment, and geography. Based on technology, the market is segmented as, cryoablation, radiofrequency (RF) ablation, microwave ablation and others. The application segment includes, lung cancer, liver cancer, kidney cancer, bone metastasis and others. Based on mode of treatment, the market is segmented as, percutaneous ablation, surgical ablation, laparoscopic ablation and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global tumor ablation market based on technology, application, mode of treatment, and geography. It also provides market size and forecast till 2027 for overall tumor ablation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the tumor ablation market in the coming years, owing to factors such as, enhanced healthcare infrastructure and rising occurrence of cancer in United States and Canada. In addition, increasing health tourism due to inferior treatment charges in Asia Pacific region it is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key tumor ablation market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Healthtronics, Inc., Boston Scientific Corporation, Misonix, Inc., Mermaid Medical A/S, Neuwave Medical, Inc., Medtronic, PLC, Angiodynamics, Inc., Galil Medical, Inc., Edap Tms S.A., Sonacare Medical LLC
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. TUMOR ABLATION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Tumor Ablation Market - By Technology
3.2.2. Tumor Ablation Market - By Application
3.2.3. Tumor Ablation Market - By Mode of Treatment
3.2.4. Tumor Ablation Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. TUMOR ABLATION MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. TUMOR ABLATION MARKET - GLOBAL ANALYSIS
5.1. GLOBAL TUMOR ABLATION MARKET OVERVIEW
5.2. GLOBAL TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. TUMOR ABLATION MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. CRYOABLATION MARKET
7.3.1. Overview
7.3.2. Cryoablation Market Revenue Forecasts and Analysis (US$ Mn)
7.4. RADIOFREQUENCY (RF) ABLATION MARKET
7.4.1. Overview
7.4.2. Radiofrequency (RF) Ablation Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MICROWAVE ABLATION MARKET
7.5.1. Overview
7.5.2. Microwave Ablation Market Revenue Forecasts and Analysis (US$ Mn)
7.6. OTHERS MARKET
7.6.1. Overview
7.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. LUNG CANCER MARKET
8.3.1. Overview
8.3.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4. LIVER CANCER MARKET
8.4.1. Overview
8.4.2. Liver Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.5. KIDNEY CANCER MARKET
8.5.1. Overview
8.5.2. Kidney Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.6. BONE METASTASIS MARKET
8.6.1. Overview
8.6.2. Bone Metastasis Market Revenue Forecasts and Analysis (US$ Mn)
8.7. OTHERS MARKET
8.7.1. Overview
8.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY MODE OF TREATMENT
9.1. OVERVIEW
9.2. MODE OF TREATMENT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PERCUTANEOUS ABLATION MARKET
9.3.1. Overview
9.3.2. Percutaneous Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.4. SURGICAL ABLATION MARKET
9.4.1. Overview
9.4.2. Surgical Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.5. LAPAROSCOPIC ABLATION MARKET
9.5.1. Overview
9.5.2. Laparoscopic Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHERS MARKET
9.6.1. Overview
9.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. NORTH AMERICA TUMOR ABLATION MARKET OVERVIEW
10.2. NORTH AMERICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.4. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
10.6. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.7. US MARKET OVERVIEW
10.7.1. US Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.2. US Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. US Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.2. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.2. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
11. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. EUROPE TUMOR ABLATION MARKET OVERVIEW
11.2. EUROPE TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.4. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
11.6. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.7. UK MARKET OVERVIEW
11.7.1. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.2. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.2. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.2. France Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. France Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC TUMOR ABLATION MARKET OVERVIEW
12.2. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.4. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
12.6. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.2. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.2. China Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. China Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.2. India Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. India Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.4. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
13.6. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.7.2. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.8.2. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.8.3. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.9.2. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.9.3. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
14. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.7.2. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14.7.3. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
16. TUMOR ABLATION MARKET, KEY COMPANY PROFILES
16.1. HEALTHTRONICS, INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. BOSTON SCIENTIFIC CORPORATION
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. MISONIX, INC.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. MERMAID MEDICAL A/S
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. NEUWAVE MEDICAL, INC.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. MEDTRONIC, PLC.
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. Product Pipeline
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.7. ANGIODYNAMICS, INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. GALIL MEDICAL, INC.
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. EDAP TMS S.A.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. SONACARE MEDICAL LLC
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. TUMOR ABLATION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Tumor Ablation Market - By Technology
3.2.2. Tumor Ablation Market - By Application
3.2.3. Tumor Ablation Market - By Mode of Treatment
3.2.4. Tumor Ablation Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. TUMOR ABLATION MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. TUMOR ABLATION MARKET - GLOBAL ANALYSIS
5.1. GLOBAL TUMOR ABLATION MARKET OVERVIEW
5.2. GLOBAL TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. TUMOR ABLATION MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. CRYOABLATION MARKET
7.3.1. Overview
7.3.2. Cryoablation Market Revenue Forecasts and Analysis (US$ Mn)
7.4. RADIOFREQUENCY (RF) ABLATION MARKET
7.4.1. Overview
7.4.2. Radiofrequency (RF) Ablation Market Revenue Forecasts and Analysis (US$ Mn)
7.5. MICROWAVE ABLATION MARKET
7.5.1. Overview
7.5.2. Microwave Ablation Market Revenue Forecasts and Analysis (US$ Mn)
7.6. OTHERS MARKET
7.6.1. Overview
7.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. LUNG CANCER MARKET
8.3.1. Overview
8.3.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4. LIVER CANCER MARKET
8.4.1. Overview
8.4.2. Liver Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.5. KIDNEY CANCER MARKET
8.5.1. Overview
8.5.2. Kidney Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.6. BONE METASTASIS MARKET
8.6.1. Overview
8.6.2. Bone Metastasis Market Revenue Forecasts and Analysis (US$ Mn)
8.7. OTHERS MARKET
8.7.1. Overview
8.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - BY MODE OF TREATMENT
9.1. OVERVIEW
9.2. MODE OF TREATMENT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PERCUTANEOUS ABLATION MARKET
9.3.1. Overview
9.3.2. Percutaneous Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.4. SURGICAL ABLATION MARKET
9.4.1. Overview
9.4.2. Surgical Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.5. LAPAROSCOPIC ABLATION MARKET
9.5.1. Overview
9.5.2. Laparoscopic Ablation Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHERS MARKET
9.6.1. Overview
9.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. NORTH AMERICA TUMOR ABLATION MARKET OVERVIEW
10.2. NORTH AMERICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.4. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
10.6. NORTH AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.7. US MARKET OVERVIEW
10.7.1. US Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.2. US Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. US Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.2. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Canada Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.2. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. Mexico Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of treatment (US$ Mn)
11. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. EUROPE TUMOR ABLATION MARKET OVERVIEW
11.2. EUROPE TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.4. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
11.6. EUROPE TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.7. UK MARKET OVERVIEW
11.7.1. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.2. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. UK Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.2. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. Germany Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.2. France Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. France Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC TUMOR ABLATION MARKET OVERVIEW
12.2. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.4. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
12.6. ASIA PACIFIC TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.2. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. Japan Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.2. China Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. China Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.2. India Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. India Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.4. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
13.6. MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.7.2. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. South Africa Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.8.2. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.8.3. Saudi Arabia Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.9.2. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.9.3. UAE Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
14. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY MODE OF TREATMENT (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA TUMOR ABLATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.7.2. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14.7.3. Brazil Tumor Ablation Market Revenue Forecasts and Analysis - By Mode of Treatment (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
16. TUMOR ABLATION MARKET, KEY COMPANY PROFILES
16.1. HEALTHTRONICS, INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. BOSTON SCIENTIFIC CORPORATION
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. MISONIX, INC.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. MERMAID MEDICAL A/S
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. NEUWAVE MEDICAL, INC.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. MEDTRONIC, PLC.
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. Product Pipeline
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.7. ANGIODYNAMICS, INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. GALIL MEDICAL, INC.
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. EDAP TMS S.A.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. SONACARE MEDICAL LLC
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies
1 Healthtronics, inc.
2 Boston scientific corporation
3 Misonix, inc.
4 Mermaid medical a/s
5 Neuwave medical, inc.
6 Medtronic, plc.
7 Angiodynamics, inc.
8 Galil medical, inc.
9 Edap tms s.a.
10 Sonacare medical llc
1 Healthtronics, inc.
2 Boston scientific corporation
3 Misonix, inc.
4 Mermaid medical a/s
5 Neuwave medical, inc.
6 Medtronic, plc.
7 Angiodynamics, inc.
8 Galil medical, inc.
9 Edap tms s.a.
10 Sonacare medical llc